Tubeimoside I protects against sepsis-induced cardiac dysfunction via SIRT3.
Cheng Z, Lv D, Luo M, Wang R, Guo Y, Yang X, Huang L, Li X, Li C, Shang FF, Huang B, Shen J, Luo S, Yan J.
Cheng Z, et al.
Eur J Pharmacol. 2021 Aug 15;905:174186. doi: 10.1016/j.ejphar.2021.174186. Epub 2021 May 24.
Eur J Pharmacol. 2021.
PMID: 34033817